Embecta operates within the global medical device, diabetes care, and injection accessories market, competing against major healthcare and pharmaceutical enterprises. Its primary industry competitors include global medical technology giants such as Medtronic, Abbott Laboratories, DexCom, Ypsomed, and various international manufacturers producing insulin delivery systems, pen needles, blood glucose monitoring equipment, and chronic care medical supplies.